UnknownNot Applicable

CTC in Lung Caner Patients With Bone Metastases

China160 participantsStarted 2020-10-01

Plain-language summary

1. Evaluate the feasibility of single cell sequencing technology based on three-dimensional bionic capture network; 2. To build a risk prediction model of bone related events based on single cell sequencing; 3. To verify the risk prediction model of bone related events by single cell sequencing; 4. To verify the comprehensive treatment of non-small cell lung cancer ( NSCLC) bone metastases.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age 18-75 years
✓. pathology-proven diagnosis of lung cancer and radiographical/pathological evidence of BM
✓. no previous treatment for BM
✓. good general condition (Eastern Cooperative Oncology Group, ECOG Performance scores: 0-2) with an estimated survival time \> 3 months.

What they're measuring

SREs（Skeletal related events）

Timeframe: 1 year

Trial details

NCT IDNCT04568291

SponsorShanghai 6th People's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-31

View on ClinicalTrials.gov More Lung Cancer trials